- Home
- HURA vs FNWD Comparison
HURA vs FNWD Comparison
Compare HURA & FNWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HURA
- FNWD
- Stock Information
- Founded
- HURA 2009
- FNWD 1994
- Country
- HURA United States
- FNWD United States
- Employees
- HURA N/A
- FNWD N/A
- Industry
- HURA
- FNWD Savings Institutions
- Sector
- HURA
- FNWD Finance
- Exchange
- HURA Nasdaq
- FNWD Nasdaq
- Market Cap
- HURA 131.8M
- FNWD 137.5M
- IPO Year
- HURA N/A
- FNWD N/A
- Fundamental
- Price
- HURA $2.29
- FNWD $33.06
- Analyst Decision
- HURA Strong Buy
- FNWD Buy
- Analyst Count
- HURA 2
- FNWD 1
- Target Price
- HURA $11.50
- FNWD $34.00
- AVG Volume (30 Days)
- HURA 181.8K
- FNWD 23.7K
- Earning Date
- HURA 11-13-2025
- FNWD 10-24-2025
- Dividend Yield
- HURA N/A
- FNWD 1.45%
- EPS Growth
- HURA N/A
- FNWD N/A
- EPS
- HURA N/A
- FNWD 1.24
- Revenue
- HURA N/A
- FNWD $63,780,000.00
- Revenue This Year
- HURA N/A
- FNWD N/A
- Revenue Next Year
- HURA N/A
- FNWD $7.77
- P/E Ratio
- HURA N/A
- FNWD $26.71
- Revenue Growth
- HURA N/A
- FNWD N/A
- 52 Week Low
- HURA $1.80
- FNWD $26.12
- 52 Week High
- HURA $7.20
- FNWD $34.40
- Technical
- Relative Strength Index (RSI)
- HURA 39.99
- FNWD 62.01
- Support Level
- HURA $2.16
- FNWD $31.90
- Resistance Level
- HURA $2.61
- FNWD $33.29
- Average True Range (ATR)
- HURA 0.13
- FNWD 1.08
- MACD
- HURA -0.02
- FNWD 0.07
- Stochastic Oscillator
- HURA 25.51
- FNWD 64.44
About HURA TuHURA Biosciences Inc. Common Stock
TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.
About FNWD Finward Bancorp
Finward Bancorp is a bank holding company, which engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Saving Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out through the United States.